סך הכנסות החברה BioLineRx (BLRX)

סמל תאגידי ולוגו של BioLineRx Ltd (BLRX)

Marketing expenses for Aphexda are temporarily weighing on profitability, creating a backdrop of uncertainty. The sales trajectory for BioLineRx Ltd. (BLRX), as illustrated by the GURU.Markets data on this chart, demonstrates local dynamics, while the value of 0.00 expresses the metric level. The potential of BioLineRx Ltd. (BLRX) is based on oncology expansion through B2B partnerships, and its status as a key player is solidified by the successful launch of its cell mobilization drug.

BLRX - הכנסות החברה BioLineRx בטווח 04.07.2022 - 13.11.2026

פילוחים אנליטיים של חברת BioLineRx (BLRX)

- שווי מניות ותחזית קונצנזוס למחירים:
ניתוח כללי של החברה:BioLineRx Corporation - BLRX
מוצר סדרתי של BioLineRx Ltd.

BioLineRx Ltd. (BLRX) sales reflect the aggregate daily cash inflow from product realization. By analyzing the company's sales dynamics, an investor can filter out market noise and identify long-term fundamental trends. This metric measures operational efficiency via daily revenue, allowing for a comparison of current growth rates against historical cycles. For BioLineRx Ltd. (BLRX), such indicators confirm the commercial success of their innovative drugs in the therapy of hematological diseases.